Serial 86340095
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 30 May 2023)
What this means for you
Registered since 03 Jan 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86340095
- Registration number
- 5114953
- Mark type
- Design / logo
- Filed
- 17 Jul 2014
- Published for opposition
- 23 Sept 2014
- Registered
- 03 Jan 2017
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in stimulating white blood cell production, available by prescription
Owner
- SANDOZ AG, BASEL, CH
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
Prosecution history
- 07 Mar 2026 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 06 Dec 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 30 May 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 30 May 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 30 May 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 18 Nov 2022 — TEAS SECTION 8 & 15 RECEIVED
- 03 Jan 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 03 Jan 2017 — REGISTERED-PRINCIPAL REGISTER
- 29 Nov 2016 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 26 Nov 2016 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 23 Nov 2016 — STATEMENT OF USE PROCESSING COMPLETE
- 10 Nov 2016 — USE AMENDMENT FILED
- 10 Nov 2016 — TEAS STATEMENT OF USE RECEIVED
- 17 Jun 2016 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Jun 2016 — SOU EXTENSION 3 GRANTED